Combination therapy
AssigneeLeap Therapeutics, Inc.
InventorsMichael H. Kagey, Cynthia A. Sirard, Michael Haas
Life of this patent
Estimating the term…
Abstract
The invention relates to methods of treating colorectal cancer in a subject in need thereof. The methods comprising co-administering to the subject: a) a DKK1 antibody, or antigen binding-fragment thereof; b) a VEGF or VEGFR inhibitor; and c) optionally one or more chemotherapeutic agents or a pharmaceutically acceptable salt of any of the foregoing, in an effective amount. The present invention also provides a pharmaceutical composition and a kit comprising a combination of a DKK1 antibody, and a VEGF or VEGFR inhibitor and optionally one or more chemotherapeutic agents.
Claims42
A method of treating colorectal cancer in a subject in need of treatment, the method comprising co-administering to the subject:
- a) a DKK1 antibody, or antigen binding-fragment thereof;
- b) a VEGF or VEGFR inhibitor;
- and
- c) optionally one or more chemotherapeutic agents
- or a pharmaceutically acceptable salt of any of the foregoing, in an effective amount.
A pharmaceutical composition comprising:
- a) a DKK1 antibody, or antigen binding-fragment thereof;
- b) a VEGF or a VEGFR inhibitor;
- and
- c) one or more chemotherapeutic agents or a pharmaceutically acceptable salt of any of the foregoing.
A pharmaceutical composition comprising:
- a) a DKK1 antibody, or antigen binding-fragment thereof;
- b) bevacizumab;
- and
- c) one or more chemotherapeutic agents or a pharmaceutically acceptable salt of any of the foregoing.
A kit comprising:
- a) a DKK1 antibody, or antigen binding-fragment thereof;
- b) a VEGF or a VEGFR inhibitor;
- c) one or more chemotherapeutic agents or a pharmaceutically acceptable salt thereof;
- and
- d) instructions for use.
A kit comprising:
- a) a DKK1 antibody, or antigen binding-fragment thereof;
- b) bevacizumab;
- c) one or more chemotherapeutic agents or a pharmaceutically acceptable salt thereof;
- and
- d) instructions for use.
Dependencies are inferred from the claim text.